Clinical Trial Update: Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating escalating doses of aspirin to prevent recurrent preterm birth. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: The George Washington University Biostatistics Center | Conditions: Preterm Delivery, Obstetrical Complications | Phase 3 | Status: RECRUITING